Sun Pharma launches Kapspargo Sprinkle formulation in US
New Delhi: Drug major Sun Pharmaceutical Industries said it has launched Kapspargo Sprinkle (metoprolol succinate) extended-release capsules used for the treatment of hypertension, chest pain and heart failure in the US market.
Kapspargo Sprinkle pellets can be sprinkled over soft food or administered via a nasogastric tube, and are designed to facilitate long-term, once-daily administration, particularly for patients who have difficulty swallowing, Sun Pharma said in a BSE filing.
Sun Pharma North America CEO Abhay Gandhi said: "Kapspargo Sprinkle capsules may make it easier for patients to take their antihypertensive medication."
This innovative product is the latest example of Sun Pharma's use of advanced technology to create novel formulations of proven medications, he added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd